Financial statements Aj Pharma
Balance sheet data of AJ PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 59 679,55 | 113 925,34 | 284 395,71 | 343 214,33 | 628 120,57 | 901 951,40 |
| A. Fixed assets | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 59 679,55 | 65 063,29 | 284 395,71 | 343 214,33 | 628 120,57 | 901 951,40 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | 48 862,05 | - | - | - | - |
| Total liabilities | 59 679,55 | 113 925,34 | 284 395,71 | 343 214,33 | 628 120,57 | 901 951,40 |
| A. Equity | 46 502,50 | 100 431,71 | 104 804,75 | 48 794,52 | 129 264,25 | 178 276,93 |
| B. Liabilities and provisions for liabilities | 13 177,05 | 13 493,63 | 179 590,96 | 294 419,81 | 498 856,32 | 723 674,47 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | 13 177,05 | 13 493,63 | 179 590,96 | 294 419,81 | 498 856,32 | 723 655,20 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.